Home > PE Ratio > VENUS REMEDIES

VENUS REMEDIES
PE (Price/Earnings) Ratio

The Current P/E Ratio of VENUS REMEDIES is 14.07.

Share Price ₹304.9Mar 27,2024
Market Cap ₹408.6 Cr
Earnings-TTM₹29.0 CrTTM-Consolidated Results
Price/Earnings14.07xCalculated as Market Cap/Earnings
Explore Stock Analytics
COMMUNITY POLL
for VENUS REMEDIES
Please provide your vote to see the results

Definition & Calculation of PE (Price/Earnings) ratio of VENUS REMEDIES

Price-to-Earnings ratio, P/E Multiple, or P/E Ratio is an important valuation multiple that is defined as:

P/E = Market Capitalization / Net Income

or, using per-share numbers:

P/E = Stock Price / Earnings Per Share (EPS)

Applying the above formula, P/E ratio of VENUS REMEDIES is calculated as :

Current Market Cap [ ₹408.6 Cr] as on Mar 27,2024

(/) Earnings [ ₹29.0 Cr] based on TTM-Consolidated Results

(=) P/E Ratio [ 14.07x ]

P/E Ratio indicates the multiple of earnings investors are willing to pay to own one share of the company.

Thus, for VENUS REMEDIES , the investors are currently willing to pay 14.07 times earnings to own 1 share of the company.

PE Multiples are the most widely used valuation multiple in practice.

Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.

In such cases, you may consider using Price to Book ratio or Price to Sales ratio of VENUS REMEDIES !

P/E ratios, also, would not adjust for differences in the capital structure between companies.

The chart below summarizes the trend in P/E Ratio of VENUS REMEDIES over the last five years.

Historical PE (Price/Earnings) ratio chart of VENUS REMEDIES


PE Ratio Performance Analysis for VENUS REMEDIES

- VENUS REMEDIES 's latest p/e ratio is 14.07x.

- VENUS REMEDIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 4.49x.

- VENUS REMEDIES 's operated at median p/e ratio of 5.49x from fiscal years ending March 2018 to 2022.

- Looking back at the last 5 fiscal years, VENUS REMEDIES 's p/e ratio peaked in Mar2022 at 8.82x.

- VENUS REMEDIES 's p/e ratio hit its five-year low in Mar2020 of 0x.


How does VENUS REMEDIES 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?

Peer Comparison (Pharmaceuticals & Drugs Industry)Earnings-TTM (Cr)PE RatioMarket Cap
VENUS REMEDIES 29.0314.07408.6
SUN PHARMACEUTICAL INDUSTRIES LTD8,998.6342.88385,837.0
DIVIS LABORATORIES LTD1,382.9764.5989,323.5
CIPLA LTD3,744.0331.62118,376.0
DR REDDYS LABORATORIES LTD5,209.4019.37100,885.0
TORRENT PHARMACEUTICALS LTD1,494.0058.0986,779.1
ABBOTT INDIA LTD1,145.5849.6256,838.6
ZYDUS LIFESCIENCES LTD2,954.2034.05100,583.0
ALKEM LABORATORIES LTD1,574.6637.9659,770.5
LUPIN LTD1,809.7440.2472,826.6
BIOCON LTD1,611.0019.1230,807.4

Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs VENUS REMEDIES 's P/E Ratio

Top 10 Industry PeersPE Ratio
Min industry PE 14.07x
Max industry PE 64.59x
Median industry PE 37.96x
Average industry PE 37.42x



You may also like the below Video Courses